| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |